View ValuationRishiroop 将来の成長Future 基準チェック /06現在、 Rishiroopの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長20.6%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 02Rishiroop Limited to Report Q4, 2026 Results on May 16, 2026Rishiroop Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 16, 2026Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹87.50, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 7.1% over the past three years.Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹3.74 (vs ₹2.73 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹3.74 (up from ₹2.73 loss in 3Q 2025). Revenue: ₹193.1m (up 13% from 3Q 2025). Net income: ₹34.3m (up ₹59.3m from 3Q 2025). Profit margin: 18% (up from net loss in 3Q 2025). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.お知らせ • Jan 28Rishiroop Limited to Report Q3, 2026 Results on Feb 10, 2026Rishiroop Limited announced that they will report Q3, 2026 results on Feb 10, 2026New Risk • Jan 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹900.3m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.4% per year over the past 5 years. Market cap is less than US$10m (₹900.3m market cap, or US$9.96m). Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin).New Risk • Nov 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 61% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₹977.8m market cap, or US$11.0m).Reported Earnings • Nov 09Second quarter 2026 earnings released: EPS: ₹0.24 (vs ₹8.06 in 2Q 2025)Second quarter 2026 results: EPS: ₹0.24 (down from ₹8.06 in 2Q 2025). Revenue: ₹169.7m (down 19% from 2Q 2025). Net income: ₹2.19m (down 97% from 2Q 2025). Profit margin: 1.3% (down from 35% in 2Q 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.お知らせ • Oct 29Rishiroop Limited to Report Q2, 2026 Results on Nov 08, 2025Rishiroop Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 08, 2025Board Change • Sep 15Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sitendu Sharma was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Aug 25Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 01 September 2025. Payment date: 08 October 2025. Payout ratio is a comfortable 13% but the company is paying out more than the cash it is generating. Trailing yield: 1.2%. Lower than top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.7%).Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹9.46 (vs ₹8.92 in 1Q 2025)First quarter 2026 results: EPS: ₹9.46 (up from ₹8.92 in 1Q 2025). Revenue: ₹266.7m (up 51% from 1Q 2025). Net income: ₹86.7m (up 6.1% from 1Q 2025). Profit margin: 33% (down from 46% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 11Rishiroop Limited, Annual General Meeting, Sep 08, 2025Rishiroop Limited, Annual General Meeting, Sep 08, 2025, at 11:00 Indian Standard Time.お知らせ • Jul 25Rishiroop Limited to Report Q1, 2026 Results on Aug 11, 2025Rishiroop Limited announced that they will report Q1, 2026 results on Aug 11, 2025New Risk • May 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 107% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (118% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (14% net profit margin). Market cap is less than US$100m (₹1.08b market cap, or US$12.6m).Reported Earnings • May 16Full year 2025 earnings released: EPS: ₹11.64 (vs ₹26.36 in FY 2024)Full year 2025 results: EPS: ₹11.64 (down from ₹26.36 in FY 2024). Revenue: ₹840.8m (up 9.7% from FY 2024). Net income: ₹106.6m (down 56% from FY 2024). Profit margin: 13% (down from 32% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • May 05Rishiroop Limited to Report Q4, 2025 Results on May 15, 2025Rishiroop Limited announced that they will report Q4, 2025 results on May 15, 2025Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₹135, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 6.9% over the past three years.Buy Or Sell Opportunity • Feb 11Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 39% to ₹150. The fair value is estimated to be ₹192, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.4% over the last 3 years. Earnings per share has grown by 13%.お知らせ • Jan 28Rishiroop Limited to Report Q3, 2025 Results on Feb 10, 2025Rishiroop Limited announced that they will report Q3, 2025 results on Feb 10, 2025Reported Earnings • Nov 12Second quarter 2025 earnings released: EPS: ₹8.06 (vs ₹4.91 in 2Q 2024)Second quarter 2025 results: EPS: ₹8.06 (up from ₹4.91 in 2Q 2024). Revenue: ₹280.9m (up 43% from 2Q 2024). Net income: ₹73.8m (up 64% from 2Q 2024). Profit margin: 26% (up from 23% in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings.お知らせ • Oct 25Rishiroop Limited to Report Q2, 2025 Results on Nov 11, 2024Rishiroop Limited announced that they will report Q2, 2025 results on Nov 11, 2024Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹227, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 90% over the past three years.Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: ₹8.92 (vs ₹7.36 in 1Q 2024)First quarter 2025 results: EPS: ₹8.92 (up from ₹7.36 in 1Q 2024). Revenue: ₹272.9m (up 59% from 1Q 2024). Net income: ₹81.7m (up 21% from 1Q 2024). Profit margin: 30% (down from 39% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.お知らせ • Aug 02Rishiroop Limited to Report Q1, 2025 Results on Aug 12, 2024Rishiroop Limited announced that they will report Q1, 2025 results on Aug 12, 2024Upcoming Dividend • Jul 29Upcoming dividend of ₹1.80 per shareEligible shareholders must have bought the stock before 05 August 2024. Payment date: 11 September 2024. Payout ratio is a comfortable 6.8% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%).お知らせ • Jul 16Rishiroop Limited, Annual General Meeting, Aug 12, 2024Rishiroop Limited, Annual General Meeting, Aug 12, 2024, at 11:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹154, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 50% over the past three years.Buy Or Sell Opportunity • Jun 04Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to ₹154. The fair value is estimated to be ₹203, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years. Earnings per share has declined by 34%.Reported Earnings • May 22Full year 2024 earnings released: EPS: ₹26.36 (vs ₹8.84 in FY 2023)Full year 2024 results: EPS: ₹26.36 (up from ₹8.84 in FY 2023). Revenue: ₹984.0m (up 11% from FY 2023). Net income: ₹241.6m (up 198% from FY 2023). Profit margin: 25% (up from 9.1% in FY 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has increased by 27% per year, which means it is well ahead of earnings.お知らせ • May 10Rishiroop Limited to Report Q4, 2024 Results on May 21, 2024Rishiroop Limited announced that they will report Q4, 2024 results on May 21, 2024Valuation Update With 7 Day Price Move • Feb 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹170, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.Reported Earnings • Feb 13Third quarter 2024 earnings released: EPS: ₹8.39 (vs ₹2.69 in 3Q 2023)Third quarter 2024 results: EPS: ₹8.39 (up from ₹2.69 in 3Q 2023). Revenue: ₹269.9m (up 37% from 3Q 2023). Net income: ₹76.8m (up 212% from 3Q 2023). Profit margin: 28% (up from 13% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹4.91 (vs ₹6.09 in 2Q 2023)Second quarter 2024 results: EPS: ₹4.91 (down from ₹6.09 in 2Q 2023). Revenue: ₹238.5m (up 1.5% from 2Q 2023). Net income: ₹45.0m (down 19% from 2Q 2023). Profit margin: 19% (down from 24% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.お知らせ • Oct 28Rishiroop Limited to Report Q2, 2024 Results on Nov 08, 2023Rishiroop Limited announced that they will report Q2, 2024 results on Nov 08, 2023Upcoming Dividend • Aug 25Upcoming dividend of ₹1.50 per share at 1.1% yieldEligible shareholders must have bought the stock before 01 September 2023. Payment date: 08 October 2023. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.8%).Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹138, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 330% over the past three years.Reported Earnings • Aug 15First quarter 2024 earnings released: EPS: ₹7.36 (vs ₹1.29 loss in 1Q 2023)First quarter 2024 results: EPS: ₹7.36 (up from ₹1.29 loss in 1Q 2023). Revenue: ₹171.8m (down 32% from 1Q 2023). Net income: ₹67.5m (up ₹79.3m from 1Q 2023). Profit margin: 39% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 60% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 11Rishiroop Limited, Annual General Meeting, Sep 08, 2023Rishiroop Limited, Annual General Meeting, Sep 08, 2023, at 11:00 Indian Standard Time. Agenda: To consider Adoption of Financial Statements and Reports of the Board of Directors and the Auditors thereon; to consider Declaration of Dividend; to consider Appointment of Director; and to discuss other matters if any.New Risk • Aug 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (8.2% net profit margin). Market cap is less than US$100m (₹1.02b market cap, or US$12.3m).お知らせ • Jul 29Rishiroop Limited to Report Q1, 2024 Results on Aug 10, 2023Rishiroop Limited announced that they will report Q1, 2024 results on Aug 10, 2023Reported Earnings • Feb 08Third quarter 2023 earnings released: EPS: ₹2.69 (vs ₹3.56 in 3Q 2022)Third quarter 2023 results: EPS: ₹2.69 (down from ₹3.56 in 3Q 2022). Revenue: ₹212.5m (down 9.7% from 3Q 2022). Net income: ₹24.6m (down 24% from 3Q 2022). Profit margin: 12% (down from 14% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 24Rishiroop Limited to Report Q3, 2023 Results on Feb 07, 2023Rishiroop Limited announced that they will report Q3, 2023 results on Feb 07, 2023Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹6.09 (vs ₹6.39 in 2Q 2022)Second quarter 2023 results: EPS: ₹6.09 (down from ₹6.39 in 2Q 2022). Revenue: ₹279.4m (up 43% from 2Q 2022). Net income: ₹55.8m (down 10.0% from 2Q 2022). Profit margin: 20% (down from 32% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 47% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Director Atul Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Nov 03Rishiroop Limited to Report Q2, 2023 Results on Nov 12, 2022Rishiroop Limited announced that they will report Q2, 2023 results at 12:15 PM, Indian Standard Time on Nov 12, 2022Reported Earnings • Aug 11First quarter 2023 earnings released: ₹1.29 loss per share (vs ₹6.89 profit in 1Q 2022)First quarter 2023 results: ₹1.29 loss per share (down from ₹6.89 profit in 1Q 2022). Revenue: ₹253.1m (up 51% from 1Q 2022). Net loss: ₹11.8m (down 118% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 28Rishiroop Limited to Report Q1, 2023 Results on Aug 09, 2022Rishiroop Limited announced that they will report Q1, 2023 results on Aug 09, 2022お知らせ • Jun 25Rishiroop Limited Declares Final Dividend for the Financial Year 2021-22Rishiroop Limited approved declaration of final dividend on equity shares for the financial year 2021-22 at 15% i. e. INR 1.50 per equity share at its AGM held on June 24, 2022.Upcoming Dividend • Jun 09Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 16 June 2022. Payment date: 24 July 2022. Payout ratio is a comfortable 8.4% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Indian dividend payers (1.8%). Higher than average of industry peers (0.8%).お知らせ • May 28Rishiroop Limited, Annual General Meeting, Jun 24, 2022Rishiroop Limited, Annual General Meeting, Jun 24, 2022, at 11:00 Indian Standard Time.お知らせ • May 21Rishiroop Limited Recommends Dividend for the Financial Year Ended March 31, 2022Rishiroop Limited at the board of directors meeting held on May 20,2022, recommended dividend at the rate of 15% INR 1.50 per equity share of INR 10 each (subject to deduction of tax at source) for the financial year ended March 31, 2022, for the approval of the shareholders at the upcoming 37th Annual General Meeting of the Company.Reported Earnings • May 21Full year 2022 earnings released: EPS: ₹17.78 (vs ₹30.92 in FY 2021)Full year 2022 results: EPS: ₹17.78 (down from ₹30.92 in FY 2021). Revenue: ₹935.1m (up 71% from FY 2021). Net income: ₹168.5m (down 44% from FY 2021). Profit margin: 18% (down from 55% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 11Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹111, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 145% over the past three years.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Director Atul Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹3.56 (down from ₹5.82 in 3Q 2021). Revenue: ₹248.8m (up 31% from 3Q 2021). Net income: ₹32.5m (down 43% from 3Q 2021). Profit margin: 13% (down from 30% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹6.39 (vs ₹2.23 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹241.7m (up 93% from 2Q 2021). Net income: ₹62.0m (up 186% from 2Q 2021). Profit margin: 26% (up from 17% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 28Rishiroop Limited (BSE:526492) announces an Equity Buyback for 640,000 shares, representing 6.6% for INR 80 million.Rishiroop Limited (BSE:526492) announces a share repurchase program. Under the program, the company will repurchase up to 640,000 shares, representing 6.6% of its issued share capital for INR 80 million. The shares will be repurchased at a price of INR 125 per share. The company has fixed September 9, 2021, as record date. As of August 20, 2021, the company had 9,701,288 shares in issue.Valuation Update With 7 Day Price Move • May 28Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to ₹87.55, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.Reported Earnings • May 23Full year 2021 earnings released: EPS ₹30.92 (vs ₹2.93 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹660.7m (up 63% from FY 2020). Net income: ₹300.0m (up ₹328.4m from FY 2020). Profit margin: 45% (up from net loss in FY 2020). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.お知らせ • May 22Rishiroop Limited Recommends Dividend for the Year Ended March 31, 2021Rishiroop Limited announced that at its board meeting held on May 21, 2021, the board of directors recommended dividend at 12% that is INR 1.20 per equity share of INR 10/- each (subject to deduction of tax at source) for the financial year ended March 31, 2021, for the approval of the shareholders at the upcoming 36th Annual General Meeting of the company. Dividend, if approved by the shareholders, will be paid/dispatched within the statutory period as prescribed under Companies Act, 2013.Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹102, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 19x in the Chemicals industry in India. Negligible returns to shareholders over past three years.Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹92.25, the stock is trading at a trailing P/E ratio of 16.9x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 23%.Upcoming Dividend • Feb 10Upcoming Dividend of ₹5.00 Per ShareWill be paid on the 5th of March to those who are registered shareholders by the 17th of February. The trailing yield of 5.4% is in the top quartile of Indian dividend payers (1.9%), and it is higher than industry peers (0.7%).Reported Earnings • Feb 06Third quarter 2021 earnings released: EPS ₹5.82 (vs ₹1.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹231.2m (up 176% from 3Q 2020). Net income: ₹56.5m (up 421% from 3Q 2020). Profit margin: 24% (up from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Feb 04New 90-day high: ₹72.00The company is up 83% from its price of ₹39.30 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.お知らせ • Jan 28Rishiroop Limited to Report Q3, 2021 Results on Feb 05, 2021Rishiroop Limited announced that they will report Q3, 2021 results on Feb 05, 2021Valuation Update With 7 Day Price Move • Nov 25Market bids up stock over the past weekAfter last week's 18% share price gain to ₹59.90, the stock is trading at a trailing P/E ratio of 77.6x, up from the previous P/E ratio of 65.8x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 53%.Valuation Update With 7 Day Price Move • Nov 17Market bids up stock over the past weekAfter last week's 16% share price gain to ₹52.30, the stock is trading at a trailing P/E ratio of 67.8x, up from the previous P/E ratio of 58.4x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 55%.Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 25% share price gain to ₹49.25, the stock is trading at a trailing P/E ratio of 63.8x, up from the previous P/E ratio of 50.9x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 58%.Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 17% share price gain to ₹46.70, the stock is trading at a trailing P/E ratio of 60.5x, up from the previous P/E ratio of 51.8x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 53%.Reported Earnings • Nov 01First half earnings releasedOver the last 12 months the company has reported total profits of ₹7.48m, down 84% from the prior year. Total revenue was ₹397.9m over the last 12 months, down 20% from the prior year.Is New 90 Day High Low • Oct 30New 90-day high: ₹37.15The company is up 45% from its price of ₹25.70 on 31 July 2020. The Indian market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.Recent Insider Transactions • Oct 02Insider recently bought ₹66k worth of stockOn the 28th of September, Shradha Khanna bought around 2k shares on-market at roughly ₹32.77 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.お知らせ • Sep 13Rishiroop Limited to Report Q1, 2021 Results on Aug 24, 2020Rishiroop Limited announced that they will report Q1, 2021 results on Aug 24, 2020お知らせ • Jun 28Rishiroop Limited to Report Q4, 2020 Results on Jun 29, 2020Rishiroop Limited announced that they will report Q4, 2020 results on Jun 29, 2020 このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Rishiroop は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BSE:526492 - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202569499N/AN/AN/A9/30/20257114044N/A6/30/2025744112N/AN/AN/A3/31/20257441071214N/A12/31/2024754183N/AN/AN/A9/30/20247842854750N/A6/30/2024771256N/AN/AN/A3/31/20247672427072N/A12/31/2023772202N/AN/AN/A9/30/2023770150119119N/A6/30/2023808160N/AN/AN/A3/31/202388781140140N/A12/31/202292976N/AN/AN/A9/30/2022967844848N/A6/30/202292890N/AN/AN/A3/31/2022844168140158N/A12/31/2021791364N/AN/AN/A9/30/202174638826715N/A6/30/2021675347N/AN/AN/A3/31/2021546300159-110N/A12/31/202046153N/AN/AN/A9/30/202035472931N/A6/30/2020329-16N/AN/AN/A3/31/2020406-282224N/A12/31/201944138N/AN/AN/A9/30/201950048N/A48N/A6/30/201955857N/AN/AN/A3/31/201960673N/A62N/A12/31/201861145N/AN/AN/A9/30/201860850N/AN/AN/A6/30/201864674N/AN/AN/A3/31/201860381N/A2N/A12/31/201760685N/AN/AN/A9/30/201759254N/AN/AN/A6/30/201749043N/AN/AN/A3/31/201746774N/A12N/A12/31/201640527N/AN/AN/A9/30/201635824N/AN/AN/A6/30/201637126N/AN/AN/A3/31/201638424N/A-6N/A12/31/201535722N/AN/AN/A9/30/201534613N/AN/AN/A6/30/201531210N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 526492の予測収益成長が 貯蓄率 ( 6.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 526492の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 526492の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 526492の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 526492の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 526492の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/06 13:38終値2026/05/06 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Rishiroop Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Vijay MadunalaFirstCall Research
お知らせ • May 02Rishiroop Limited to Report Q4, 2026 Results on May 16, 2026Rishiroop Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 16, 2026
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹87.50, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 7.1% over the past three years.
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹3.74 (vs ₹2.73 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹3.74 (up from ₹2.73 loss in 3Q 2025). Revenue: ₹193.1m (up 13% from 3Q 2025). Net income: ₹34.3m (up ₹59.3m from 3Q 2025). Profit margin: 18% (up from net loss in 3Q 2025). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
お知らせ • Jan 28Rishiroop Limited to Report Q3, 2026 Results on Feb 10, 2026Rishiroop Limited announced that they will report Q3, 2026 results on Feb 10, 2026
New Risk • Jan 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹900.3m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.4% per year over the past 5 years. Market cap is less than US$10m (₹900.3m market cap, or US$9.96m). Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin).
New Risk • Nov 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 61% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₹977.8m market cap, or US$11.0m).
Reported Earnings • Nov 09Second quarter 2026 earnings released: EPS: ₹0.24 (vs ₹8.06 in 2Q 2025)Second quarter 2026 results: EPS: ₹0.24 (down from ₹8.06 in 2Q 2025). Revenue: ₹169.7m (down 19% from 2Q 2025). Net income: ₹2.19m (down 97% from 2Q 2025). Profit margin: 1.3% (down from 35% in 2Q 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.
お知らせ • Oct 29Rishiroop Limited to Report Q2, 2026 Results on Nov 08, 2025Rishiroop Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 08, 2025
Board Change • Sep 15Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sitendu Sharma was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Aug 25Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 01 September 2025. Payment date: 08 October 2025. Payout ratio is a comfortable 13% but the company is paying out more than the cash it is generating. Trailing yield: 1.2%. Lower than top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.7%).
Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹9.46 (vs ₹8.92 in 1Q 2025)First quarter 2026 results: EPS: ₹9.46 (up from ₹8.92 in 1Q 2025). Revenue: ₹266.7m (up 51% from 1Q 2025). Net income: ₹86.7m (up 6.1% from 1Q 2025). Profit margin: 33% (down from 46% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 11Rishiroop Limited, Annual General Meeting, Sep 08, 2025Rishiroop Limited, Annual General Meeting, Sep 08, 2025, at 11:00 Indian Standard Time.
お知らせ • Jul 25Rishiroop Limited to Report Q1, 2026 Results on Aug 11, 2025Rishiroop Limited announced that they will report Q1, 2026 results on Aug 11, 2025
New Risk • May 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 107% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (118% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (14% net profit margin). Market cap is less than US$100m (₹1.08b market cap, or US$12.6m).
Reported Earnings • May 16Full year 2025 earnings released: EPS: ₹11.64 (vs ₹26.36 in FY 2024)Full year 2025 results: EPS: ₹11.64 (down from ₹26.36 in FY 2024). Revenue: ₹840.8m (up 9.7% from FY 2024). Net income: ₹106.6m (down 56% from FY 2024). Profit margin: 13% (down from 32% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • May 05Rishiroop Limited to Report Q4, 2025 Results on May 15, 2025Rishiroop Limited announced that they will report Q4, 2025 results on May 15, 2025
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₹135, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 6.9% over the past three years.
Buy Or Sell Opportunity • Feb 11Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 39% to ₹150. The fair value is estimated to be ₹192, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.4% over the last 3 years. Earnings per share has grown by 13%.
お知らせ • Jan 28Rishiroop Limited to Report Q3, 2025 Results on Feb 10, 2025Rishiroop Limited announced that they will report Q3, 2025 results on Feb 10, 2025
Reported Earnings • Nov 12Second quarter 2025 earnings released: EPS: ₹8.06 (vs ₹4.91 in 2Q 2024)Second quarter 2025 results: EPS: ₹8.06 (up from ₹4.91 in 2Q 2024). Revenue: ₹280.9m (up 43% from 2Q 2024). Net income: ₹73.8m (up 64% from 2Q 2024). Profit margin: 26% (up from 23% in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings.
お知らせ • Oct 25Rishiroop Limited to Report Q2, 2025 Results on Nov 11, 2024Rishiroop Limited announced that they will report Q2, 2025 results on Nov 11, 2024
Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹227, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 90% over the past three years.
Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: ₹8.92 (vs ₹7.36 in 1Q 2024)First quarter 2025 results: EPS: ₹8.92 (up from ₹7.36 in 1Q 2024). Revenue: ₹272.9m (up 59% from 1Q 2024). Net income: ₹81.7m (up 21% from 1Q 2024). Profit margin: 30% (down from 39% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.
お知らせ • Aug 02Rishiroop Limited to Report Q1, 2025 Results on Aug 12, 2024Rishiroop Limited announced that they will report Q1, 2025 results on Aug 12, 2024
Upcoming Dividend • Jul 29Upcoming dividend of ₹1.80 per shareEligible shareholders must have bought the stock before 05 August 2024. Payment date: 11 September 2024. Payout ratio is a comfortable 6.8% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%).
お知らせ • Jul 16Rishiroop Limited, Annual General Meeting, Aug 12, 2024Rishiroop Limited, Annual General Meeting, Aug 12, 2024, at 11:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹154, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 50% over the past three years.
Buy Or Sell Opportunity • Jun 04Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to ₹154. The fair value is estimated to be ₹203, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years. Earnings per share has declined by 34%.
Reported Earnings • May 22Full year 2024 earnings released: EPS: ₹26.36 (vs ₹8.84 in FY 2023)Full year 2024 results: EPS: ₹26.36 (up from ₹8.84 in FY 2023). Revenue: ₹984.0m (up 11% from FY 2023). Net income: ₹241.6m (up 198% from FY 2023). Profit margin: 25% (up from 9.1% in FY 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has increased by 27% per year, which means it is well ahead of earnings.
お知らせ • May 10Rishiroop Limited to Report Q4, 2024 Results on May 21, 2024Rishiroop Limited announced that they will report Q4, 2024 results on May 21, 2024
Valuation Update With 7 Day Price Move • Feb 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹170, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.
Reported Earnings • Feb 13Third quarter 2024 earnings released: EPS: ₹8.39 (vs ₹2.69 in 3Q 2023)Third quarter 2024 results: EPS: ₹8.39 (up from ₹2.69 in 3Q 2023). Revenue: ₹269.9m (up 37% from 3Q 2023). Net income: ₹76.8m (up 212% from 3Q 2023). Profit margin: 28% (up from 13% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹4.91 (vs ₹6.09 in 2Q 2023)Second quarter 2024 results: EPS: ₹4.91 (down from ₹6.09 in 2Q 2023). Revenue: ₹238.5m (up 1.5% from 2Q 2023). Net income: ₹45.0m (down 19% from 2Q 2023). Profit margin: 19% (down from 24% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.
お知らせ • Oct 28Rishiroop Limited to Report Q2, 2024 Results on Nov 08, 2023Rishiroop Limited announced that they will report Q2, 2024 results on Nov 08, 2023
Upcoming Dividend • Aug 25Upcoming dividend of ₹1.50 per share at 1.1% yieldEligible shareholders must have bought the stock before 01 September 2023. Payment date: 08 October 2023. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.8%).
Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹138, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 330% over the past three years.
Reported Earnings • Aug 15First quarter 2024 earnings released: EPS: ₹7.36 (vs ₹1.29 loss in 1Q 2023)First quarter 2024 results: EPS: ₹7.36 (up from ₹1.29 loss in 1Q 2023). Revenue: ₹171.8m (down 32% from 1Q 2023). Net income: ₹67.5m (up ₹79.3m from 1Q 2023). Profit margin: 39% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 60% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 11Rishiroop Limited, Annual General Meeting, Sep 08, 2023Rishiroop Limited, Annual General Meeting, Sep 08, 2023, at 11:00 Indian Standard Time. Agenda: To consider Adoption of Financial Statements and Reports of the Board of Directors and the Auditors thereon; to consider Declaration of Dividend; to consider Appointment of Director; and to discuss other matters if any.
New Risk • Aug 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (8.2% net profit margin). Market cap is less than US$100m (₹1.02b market cap, or US$12.3m).
お知らせ • Jul 29Rishiroop Limited to Report Q1, 2024 Results on Aug 10, 2023Rishiroop Limited announced that they will report Q1, 2024 results on Aug 10, 2023
Reported Earnings • Feb 08Third quarter 2023 earnings released: EPS: ₹2.69 (vs ₹3.56 in 3Q 2022)Third quarter 2023 results: EPS: ₹2.69 (down from ₹3.56 in 3Q 2022). Revenue: ₹212.5m (down 9.7% from 3Q 2022). Net income: ₹24.6m (down 24% from 3Q 2022). Profit margin: 12% (down from 14% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 24Rishiroop Limited to Report Q3, 2023 Results on Feb 07, 2023Rishiroop Limited announced that they will report Q3, 2023 results on Feb 07, 2023
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹6.09 (vs ₹6.39 in 2Q 2022)Second quarter 2023 results: EPS: ₹6.09 (down from ₹6.39 in 2Q 2022). Revenue: ₹279.4m (up 43% from 2Q 2022). Net income: ₹55.8m (down 10.0% from 2Q 2022). Profit margin: 20% (down from 32% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 47% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Director Atul Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 03Rishiroop Limited to Report Q2, 2023 Results on Nov 12, 2022Rishiroop Limited announced that they will report Q2, 2023 results at 12:15 PM, Indian Standard Time on Nov 12, 2022
Reported Earnings • Aug 11First quarter 2023 earnings released: ₹1.29 loss per share (vs ₹6.89 profit in 1Q 2022)First quarter 2023 results: ₹1.29 loss per share (down from ₹6.89 profit in 1Q 2022). Revenue: ₹253.1m (up 51% from 1Q 2022). Net loss: ₹11.8m (down 118% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 28Rishiroop Limited to Report Q1, 2023 Results on Aug 09, 2022Rishiroop Limited announced that they will report Q1, 2023 results on Aug 09, 2022
お知らせ • Jun 25Rishiroop Limited Declares Final Dividend for the Financial Year 2021-22Rishiroop Limited approved declaration of final dividend on equity shares for the financial year 2021-22 at 15% i. e. INR 1.50 per equity share at its AGM held on June 24, 2022.
Upcoming Dividend • Jun 09Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 16 June 2022. Payment date: 24 July 2022. Payout ratio is a comfortable 8.4% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Indian dividend payers (1.8%). Higher than average of industry peers (0.8%).
お知らせ • May 28Rishiroop Limited, Annual General Meeting, Jun 24, 2022Rishiroop Limited, Annual General Meeting, Jun 24, 2022, at 11:00 Indian Standard Time.
お知らせ • May 21Rishiroop Limited Recommends Dividend for the Financial Year Ended March 31, 2022Rishiroop Limited at the board of directors meeting held on May 20,2022, recommended dividend at the rate of 15% INR 1.50 per equity share of INR 10 each (subject to deduction of tax at source) for the financial year ended March 31, 2022, for the approval of the shareholders at the upcoming 37th Annual General Meeting of the Company.
Reported Earnings • May 21Full year 2022 earnings released: EPS: ₹17.78 (vs ₹30.92 in FY 2021)Full year 2022 results: EPS: ₹17.78 (down from ₹30.92 in FY 2021). Revenue: ₹935.1m (up 71% from FY 2021). Net income: ₹168.5m (down 44% from FY 2021). Profit margin: 18% (down from 55% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 11Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹111, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 145% over the past three years.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Director Atul Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹3.56 (down from ₹5.82 in 3Q 2021). Revenue: ₹248.8m (up 31% from 3Q 2021). Net income: ₹32.5m (down 43% from 3Q 2021). Profit margin: 13% (down from 30% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹6.39 (vs ₹2.23 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹241.7m (up 93% from 2Q 2021). Net income: ₹62.0m (up 186% from 2Q 2021). Profit margin: 26% (up from 17% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 28Rishiroop Limited (BSE:526492) announces an Equity Buyback for 640,000 shares, representing 6.6% for INR 80 million.Rishiroop Limited (BSE:526492) announces a share repurchase program. Under the program, the company will repurchase up to 640,000 shares, representing 6.6% of its issued share capital for INR 80 million. The shares will be repurchased at a price of INR 125 per share. The company has fixed September 9, 2021, as record date. As of August 20, 2021, the company had 9,701,288 shares in issue.
Valuation Update With 7 Day Price Move • May 28Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to ₹87.55, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.
Reported Earnings • May 23Full year 2021 earnings released: EPS ₹30.92 (vs ₹2.93 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹660.7m (up 63% from FY 2020). Net income: ₹300.0m (up ₹328.4m from FY 2020). Profit margin: 45% (up from net loss in FY 2020). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
お知らせ • May 22Rishiroop Limited Recommends Dividend for the Year Ended March 31, 2021Rishiroop Limited announced that at its board meeting held on May 21, 2021, the board of directors recommended dividend at 12% that is INR 1.20 per equity share of INR 10/- each (subject to deduction of tax at source) for the financial year ended March 31, 2021, for the approval of the shareholders at the upcoming 36th Annual General Meeting of the company. Dividend, if approved by the shareholders, will be paid/dispatched within the statutory period as prescribed under Companies Act, 2013.
Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹102, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 19x in the Chemicals industry in India. Negligible returns to shareholders over past three years.
Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹92.25, the stock is trading at a trailing P/E ratio of 16.9x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 23%.
Upcoming Dividend • Feb 10Upcoming Dividend of ₹5.00 Per ShareWill be paid on the 5th of March to those who are registered shareholders by the 17th of February. The trailing yield of 5.4% is in the top quartile of Indian dividend payers (1.9%), and it is higher than industry peers (0.7%).
Reported Earnings • Feb 06Third quarter 2021 earnings released: EPS ₹5.82 (vs ₹1.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹231.2m (up 176% from 3Q 2020). Net income: ₹56.5m (up 421% from 3Q 2020). Profit margin: 24% (up from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Feb 04New 90-day high: ₹72.00The company is up 83% from its price of ₹39.30 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.
お知らせ • Jan 28Rishiroop Limited to Report Q3, 2021 Results on Feb 05, 2021Rishiroop Limited announced that they will report Q3, 2021 results on Feb 05, 2021
Valuation Update With 7 Day Price Move • Nov 25Market bids up stock over the past weekAfter last week's 18% share price gain to ₹59.90, the stock is trading at a trailing P/E ratio of 77.6x, up from the previous P/E ratio of 65.8x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 53%.
Valuation Update With 7 Day Price Move • Nov 17Market bids up stock over the past weekAfter last week's 16% share price gain to ₹52.30, the stock is trading at a trailing P/E ratio of 67.8x, up from the previous P/E ratio of 58.4x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 55%.
Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 25% share price gain to ₹49.25, the stock is trading at a trailing P/E ratio of 63.8x, up from the previous P/E ratio of 50.9x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 58%.
Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 17% share price gain to ₹46.70, the stock is trading at a trailing P/E ratio of 60.5x, up from the previous P/E ratio of 51.8x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 53%.
Reported Earnings • Nov 01First half earnings releasedOver the last 12 months the company has reported total profits of ₹7.48m, down 84% from the prior year. Total revenue was ₹397.9m over the last 12 months, down 20% from the prior year.
Is New 90 Day High Low • Oct 30New 90-day high: ₹37.15The company is up 45% from its price of ₹25.70 on 31 July 2020. The Indian market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.
Recent Insider Transactions • Oct 02Insider recently bought ₹66k worth of stockOn the 28th of September, Shradha Khanna bought around 2k shares on-market at roughly ₹32.77 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
お知らせ • Sep 13Rishiroop Limited to Report Q1, 2021 Results on Aug 24, 2020Rishiroop Limited announced that they will report Q1, 2021 results on Aug 24, 2020
お知らせ • Jun 28Rishiroop Limited to Report Q4, 2020 Results on Jun 29, 2020Rishiroop Limited announced that they will report Q4, 2020 results on Jun 29, 2020